Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 77,862
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12616711 | Therapeutic dendrimer | 🖼🧊📄§ | 2026-05-05 | 2040-09-25 | 0 | 31 |
| 12616715 | Nanotherapy targeting RHAMM-positive tumors | 🖼🧊📄§ | 2026-05-05 | 2041-04-23 | 0 | 31 |
| 12616718 | Photosynthetic cellular substances and methods of use thereof | 🖼🧊📄§ | 2026-05-05 | 2043-04-24 | 0 | 31 |
| 12616722 | Treatment of immune disorders | 🖼🧊📄§ | 2026-05-05 | 2045-01-17 | 0 | 31 |
| 12616725 | Bifidobacterium breve IDCC 4401 strain and its dead cell ID-BBR4401 having excellent acid tolerance and bile tolerance and prophylactic or therapeutic effect on dyslipidemia | 🖼🧊📄§ | 2026-05-05 | 2042-12-30 | 0 | 31 |
| 12616724 | Pharmaceutical composition for preventing or treating intestinal damage comprising Leuconostoc citreum strain as active ingredient | 🖼🧊📄§ | 2026-05-05 | 2042-02-07 | 0 | 31 |
| 12616731 | Process for enhancing organoleptic properties of natural products and natraceuticals thereof | 🖼🧊📄§ | 2026-05-05 | 2041-09-22 | 0 | 31 |
| 12616728 | Processes and systems for converting cannabinoids into cannabinoid derivatives and isolating the same | 🖼🧊📄§ | 2026-05-05 | 2043-11-21 | 0 | 31 |
| 12616732 | Peptides for treatment of medical disorders | 🖼🧊📄§ | 2026-05-05 | 2042-07-11 | 0 | 31 |
| 12616736 | Method of diagnosis of adrenal insufficiency | 🖼🧊📄§ | 2026-05-05 | 2038-10-24 | 0 | 31 |
| 12616735 | Compositions and methods of controlling expression of thermogenin (UCP-1) in skeletal muscles | 🖼🧊📄§ | 2026-05-05 | 2039-07-03 | 0 | 31 |
| 12616738 | Solid compositions comprising a GLP-1 agonist and a salt of N-(8-(2-hydroxybenzoyl)amino)caprylic acid | 🖼🧊📄§ | 2026-05-05 | 2042-11-16 | 0 | 31 |
| 12616739 | GLP-1 prodrugs and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2041-11-05 | 0 | 31 |
| 12616743 | Streptococcal GlcNAc-lacking glycopolypeptides, cell wall carbohydrates, streptococcus vaccines, and methods for making and using them | 🖼🧊📄§ | 2026-05-05 | 2043-08-16 | 0 | 31 |
| 12616746 | Infectious disease antigens and vaccines | 🖼🧊📄§ | 2026-05-05 | 2042-10-03 | 0 | 31 |
| 12616744 | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | 🖼🧊📄§ | 2026-05-05 | 2043-12-06 | 0 | 31 |
| 12616753 | HSP70 inhibitors and methods of using same | 🖼🧊📄§ | 2026-05-05 | 2041-03-30 | 0 | 31 |
| 12616752 | Pharmaceutical compositions comprising meloxicam | 🖼🧊📄§ | 2026-05-05 | 2045-06-05 | 0 | 31 |
| 12616754 | Composition for delivery of a bioactive agent and method of manufacture and use thereof | 🖼🧊📄§ | 2026-05-05 | 2040-07-14 | 0 | 31 |
| 12616807 | Medical counter measures including dry powder formulations and associated methods | 🖼🧊📄§ | 2026-05-05 | 2044-05-20 | 0 | 31 |
| 12618031 | Delivery devices | 🖼🧊📄§ | 2026-05-05 | 2041-06-24 | 0 | 31 |
| 12616823 | Sustained release formulations in delivery devices | 🖼🧊📄§ | 2026-05-05 | 2039-09-10 | 0 | 31 |
| 12618048 | Dual CAR-T cells | 🖼🧊📄§ | 2026-05-05 | 2041-07-30 | 0 | 31 |
| 12617816 | Composition and method for in vivo assay of opioid receptors | 🖼🧊📄§ | 2026-05-05 | 2040-11-11 | 0 | 31 |
| 12611385 | Use of two-dimensional nanomaterial in inhibition of coronavirus | 🖼🧊📄§ | 2026-04-28 | 2041-02-22 | 0 | 31 |
| 12611440 | Fusion proteins and uses thereof | 🖼🧊📄§ | 2026-04-28 | 2040-09-03 | 0 | 31 |
| 12612612 | Methods for exon skipping and gene knockout using base editors | 🖼🧊📄§ | 2026-04-28 | 2039-07-19 | 0 | 31 |
| 12611451 | Neisseria meningitidis vaccine | 🖼🧊📄§ | 2026-04-28 | 2043-06-07 | 0 | 31 |
| 12611290 | Method for forming and polishing a composite denture | 🖼🧊📄§ | 2026-04-28 | 2044-08-21 | 0 | 31 |
| 12612343 | PSMA binder and use thereof | 🖼🧊📄§ | 2026-04-28 | 2041-04-13 | 0 | 31 |
| 12612441 | Polypeptide and therapeutic uses thereof | 🖼🧊📄§ | 2026-04-28 | 2040-01-07 | 0 | 31 |
| 12611433 | Anaerostipes sp B2131 strain and application thereof in inflammatory bowel diseases | 🖼🧊📄§ | 2026-04-28 | 2041-01-08 | 0 | 31 |
| 12611467 | APOE gene therapy | 🖼🧊📄§ | 2026-04-28 | 2040-11-25 | 0 | 31 |
| 12611412 | Targeting the TLK1/NEK1 axis in prostate cancer | 🖼🧊📄§ | 2026-04-28 | 2043-11-15 | 0 | 31 |
| 12611442 | mRNA encoding engineered CFTR | 🖼🧊📄§ | 2026-04-28 | 2040-09-17 | 0 | 31 |
| 12611457 | Bispecific antibodies specifically binding to PD1 and LAG3 | 🖼🧊📄§ | 2026-04-28 | 2042-03-07 | 0 | 31 |
| 12611430 | Therapeutic agent of peripheral blood flow disorder | 🖼🧊📄§ | 2026-04-28 | 2039-11-29 | 0 | 31 |
| 12611419 | Liposomal composition for use in a method of treating Parkinson's disease | 🖼🧊📄§ | 2026-04-28 | 2043-03-09 | 0 | 31 |
| 12611432 | Immunostimulatory bacteria for the treatment of cancer | 🖼🧊📄§ | 2026-04-28 | 2043-07-11 | 0 | 31 |
| 12611286 | Method and apparatus for dental crown restorations using prefabricated sleeve-crown pairs | 🖼🧊📄§ | 2026-04-28 | 2042-08-19 | 0 | 31 |
| 12611431 | Approach to sustained production and delivery of nitric oxide and S-nitrosothiols | 🖼🧊📄§ | 2026-04-28 | 2043-10-16 | 0 | 31 |
| 12612461 | Single domain antibodies against CLL-1 | 🖼🧊📄§ | 2026-04-28 | 2039-11-27 | 0 | 31 |
| 12612384 | Heterocyclic CYP4A inhibitor compounds and compositions thereof | 🖼🧊📄§ | 2026-04-28 | 2042-05-04 | 0 | 31 |
| 12612358 | Resorcinol-based compounds and uses thereof | 🖼🧊📄§ | 2026-04-28 | 2041-12-16 | 0 | 31 |
| 12611378 | Targeted release rifaximin compositions | 🖼🧊📄§ | 2026-04-28 | 2041-06-25 | 0 | 31 |
| 12611458 | Chimeric receptors and methods of use thereof | 🖼🧊📄§ | 2026-04-28 | 2043-04-14 | 0 | 31 |
| 12612602 | Production of a bioengineered lung | 🖼🧊📄§ | 2026-04-28 | 2039-04-18 | 0 | 31 |
| 12612637 | Compositions and methods for DHFR tunable protein regulation | 🖼🧊📄§ | 2026-04-28 | 2040-09-04 | 0 | 31 |
| 12611444 | IL-36 cytokine expressing oncolytic viruses for treating cancer | 🖼🧊📄§ | 2026-04-28 | 2042-03-17 | 0 | 31 |
| 12611415 | Methods and compounds for treatment of metabolic disease | 🖼🧊📄§ | 2026-04-28 | 2040-09-21 | 0 | 31 |